Jasper Therapeutics, Inc.
JSPRCIK 0001788028 · Every Form 4 filed by insiders at this issuer.
Filings
4
Latest Feb 20, 2024
Unique insiders
21
Showing
4 of 4
Page 1
Top insiders
Most active reporters at Jasper Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Abingworth Bioventures VII LP | 10% Owner | 1 |
| Abingworth LLP | 10% Owner | 1 |
| Avego Healthcare Capital Holdings, LLC | — | 1 |
| Avego Healthcare Capital, L.P. | — | 1 |
| Avego Management LLC | — | 1 |
| CG Subsidiary Holdings L.L.C. | 10% Owner | 1 |
| CROSS HERB | Officer | 1 |
| Carlyle Genesis UK LLC | 10% Owner | 1 |
| Carlyle Group Inc. | — | 1 |
| Carlyle Holdings I GP Inc. | 10% Owner | 1 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 20, 2024 | CROSS HERB Chief Financial Officer | Holdings only | — | — | — | |
| Feb 20, 2024 | MARTELL RON President, CEO and Director · Director | Holdings only | — | — | — | |
| Feb 12, 2024 | Carlyle Holdings I GP Inc. 10% Owner | P | 190,000 | $12.95 | $2,460,500 | |
| Feb 9, 2024 | Velan Capital Investment Management LP 10% Owner | P | 350,000 | $12.95 | $4,532,500 |
Showing 1–4 of 4
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.